Clinical Study of Intravenous, Low-Dose Recombinant Tissue Plasminogen Activator for Acute Cerebral Infarction: Comparison of Treatment within 3âHours versus 3-4.5âHours
Keywords: Acute ischemic stroke; low dose; recombinant tissue plasminogen activator; neuroendovascular therapy;